Consolidated Statements of Comprehensive Income Loss (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Defined Benefit Plan Disclosure [Line Items]
Revenue	$ 496,353	$ 406,278	$ 932,731	$ 743,246
Cost of Goods Sold	81,082	35,163	158,926	72,169
Gross Profit	415,271	371,115	773,805	671,077
Operating Expenses:
Research and development	4,201	2,263	9,963	2,263
Depreciation and amortization	14,881	14,881	29,761	29,761
Selling, general and administrative	345,043	337,793	695,741	632,407
Total Operating Expenses	364,125	354,937	735,465	664,431
Operating income	51,146	16,178	38,340	6,646
Other Income (Expense)
Other income				4,544
Gain (loss) on foreign currency exchange	1	1	2	(149)
Total Other Income (Expense)	(25,433)	(26,167)	(51,141)	(47,142)
Income (Loss) Before Provision for Income Taxes	25,713	(9,989)	(12,801)	(40,496)
Provision for income taxes
Net Income (Loss) from continuing operations	25,713	(9,989)	(12,801)	(40,496)
Loss from discontinued operations, net of tax	(1,826)	(49)	(1,875)	(150)
Net Income (Loss)	23,887	(10,038)	(14,676)	(40,646)
Preferred stock dividends			(162,185)	(162,185)
Net Income (Loss) Available to Common Stockholders	23,887	(10,038)	(176,861)	(202,831)
Other Comprehensive Income (Loss)
Foreign Currency Translation Adjustment
Comprehensive Income (Loss)	$ 23,887	$ (10,038)	$ (14,676)	$ (40,646)
Income loss per share from continuing operations - basic	$ 0.00	$ (0.00)	$ (0.01)	$ (0.01)
Income loss per share from continuing operations - diluted	0.00	(0.00)	(0.01)	(0.01)
Loss per share, loss from discontinued operations - basic	(0.00)	(0.00)	(0.00)	(0.00)
Loss per share, loss from discontinued operations - diluted	(0.00)	(0.00)	(0.00)	(0.00)
Income loss available to common stockholders - basic	0.00	(0.00)	(0.01)	(0.01)
Income loss available to common stockholders - diluted	$ 0.00	$ (0.00)	$ (0.01)	$ (0.01)
Weighted Average Number of Shares Outstanding – Basic	33,372,796	32,628,835	33,372,796	32,628,835
Weighted Average Number of Shares Outstanding –Diluted	38,667,862	32,628,835	33,372,796	32,628,835
Related Party [Member]
Other Income (Expense)
Interest expense	$ (12,572)	$ (12,841)	$ (25,142)	$ (24,872)
Nonrelated Party [Member]
Other Income (Expense)
Interest expense	$ (12,862)	$ (13,327)	$ (26,001)	$ (26,665)

VYCOR MEDICAL INC 10-Q